Holen Sie sich die Stockscreener-App
1.15
0.86%
-0.01
Handel nachbörslich:
1.15
Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
-0.1614 | 0.0928 | 0.0311 | 0.0375 |
Operating Expenses
|
44.32%
3.2036
|
2.2198 | 1.812 | 1.7324 | 2.2777 |
| Operating Income/Loss |
44.32%
-3.2036
|
-2.2198 | -1.812 | -1.7324 | -2.2777 |
| Income/Loss From Continuing Operations Before Tax |
246.87%
3.1343
|
-2.134 | 0.0928 | -1.7014 | -2.2401 |
| Income/Loss From Continuing Operations After Tax |
246.87%
3.1343
|
-2.134 | -1.7192 | -1.7014 | -2.2401 |
|
Net Income/Loss
|
246.87%
3.1343
|
-2.134 | -1.7192 | -1.7014 | 2.2401 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
6.2685
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):